Fleming Michael 4

4 · Merck & Co., Inc. · Filed May 5, 2020

Form 4

Period: 2020-05-01

SVP Chief Ethics & Com Officer

Transactions

Tax Payment
Common Stock
2020-05-03$77.67/sh−529$41,087→ 5,560.334 total
Award
Restricted Stock Unit
2020-05-01+2,704→ 2,704 total
From: 2021-05-01Exp: 2023-05-01→ Common Stock (2,704 underlying)
Exercise/Conversion
Restricted Stock Unit
2020-05-03−1,541→ 3,084 total
From: 2020-05-03Exp: 2022-05-03→ Common Stock (1,541 underlying)
Award
Stock Option (Right to Buy)
2020-05-01+21,144→ 21,144 total
Exercise: $77.67From: 2021-05-01Exp: 2030-04-30→ Common Stock (21,144 underlying)
Exercise/Conversion
Common Stock
2020-05-03$77.67/sh+1,541$119,689→ 6,089.334 total

Footnotes (5)

[F1]Holdings include shares acquired in dividend reinvestment transactions.
[F2]The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
[F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
[F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
[F5]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

Documents

1 file